STEPHANI SHOAF: Open Payments
NPI 1568874311 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 59 payments from 21 companies in 2025. Trend: 2023 $1,542 · 2024 $1,172 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $185 |
| Regeneron Healthcare Solutions, Inc. | 7 | $144 |
| Incyte Corporation | 5 | $120 |
| Merck Sharp & Dohme LLC | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Genentech USA, Inc. | 4 | $78 |
| Exelixis Inc. | 2 | $53 |
| Boston Scientific Corporation | 2 | $44 |
Products named: LIBTAYO, MONJUVI, Nubeqa, KEYTRUDA, RYBREVANT, PLUVICTO, CABOMETYX, TALVEY.
Industry payments across AL — which companies pay providers there.
